Ian Seppelt is an Honorary Professorial Fellow in the Critical Care and Trauma Division of The George Institute. He is a Senior Specialist and Director of Clinical Research in the Department of Intensive Care Medicine at Nepean Hospital in western Sydney with a clinical practice which includes general intensive care medicine and neuroanaesthesia.

He also has clinical appointments with the Sydney Medical School - Nepean, University of Sydney and the Department of Clinical Medicine, Macquarie University. He has been an executive member of the Australian and New Zealand Intensive Care Society's Clinical Trials Group and convenes the CTG's Point Prevalence Program and the SuDDICU (Selective Decontamination of the Digestive Tract) programs in collaboration with The George Institute. He is an investigator with the NHMRC CRE in Critical Infection, University of Sydney.

Ian is an examiner for the College of Intensive Care Medicine - Australia and New Zealand and is involved with the teaching of intensive care trainees and the development of young researchers in intensive care medicine. His ongoing interests include clinical trial methodology and research governance in critical care research, knowledge translation of research into clinical practice, trauma management and the role selective gut decontamination in critical illness.

Jayanthi is an Advanced Certified SAS Programmer with a Masters in Molecular Science and Nanotechnology from Louisiana Tech University, Louisiana, USA and another Masters in Biotechnology from Bangalore University, India.

In the last three years, she has extensively worked on statistical reporting and analysis for several studies ranging from the therapeutic areas of pain management to cardiovascular diseases. She has programmed for various Phase II, III and IV clinical trials for FDA and EMEA submissions. She has worked with GlaxoSmithKline, India and Alpharma Pharmaceuticals, USA, prior to joining The George Institute in 2011.

John Chalmers has an outstanding record in hypertension research, both fundamental and clinical. His groundbreaking research on the role of the brain in the development of hypertension led to his election to Fellowship of the Australian Academy of Science and helped establish Flinders University as a leading international centre in hypertension and neuroscience research.

His studies on the treatment of high blood pressure for the prevention of heart attack and stroke have changed the way patients are treated throughout the world. His work has been recognised through many awards including the Wellcome Medal, the RT Hall Prize of the Cardiac Society of Australia and New Zealand, The Zanchetti Lifetime Achievement Award of the European Society of Hypertension and the Volhard Medal of the International Society of Hypertension.

He has been President or Chairman of the Australian Society of Medical Research, The Royal Australasian College of Physicians, the National Health and Medical Research Council of Australia, the WHO Expert Committee on Hypertension, the International Society of Hypertension and the Scientific Advisory Board of the World Heart Federation.

Professor Chalmers' contribution to medical science has been acknowledged through the award of many Honorary Doctoral degrees and extensive appointments on national and international boards and advisory committees. He was appointed a Companion in the Order of Australia (AC) in 1991 and an Officer in the National Order of Merit of France in 2010.

John Chalmers remains an active researcher at The George Institute Australia, where he is a principal investigator on many research grants and Chair of steering committees for major studies, mentors young clinical researchers from around the world, and continues to publish and lecture prolifically. 

Professor John A Myburgh AO, MBBCh (University of Witwatersrand), PhD (University of Adelaide), FCICM FAHMS FAICD, is Professor of Intensive Care Medicine, University of New South Wales; Director of the Professoriate and Immediate-Past Director of the Critical Care Research Program at the George Institute for Global Health, Sydney, Senior Intensive Care Physician and Director of Research at St George Hospital, Sydney.

He is Leadership Fellow of the National Health and Medical Research Council and honorary Professor at the Monash University School of Public Health and Preventive Medicine.

He has delivered over 45 years of clinical practice, designed and conducted over 75 basic science and clinical trials in fundamental areas of Intensive Care Medicine, including catecholamine pharmacology, traumatic brain injury, fluid resuscitation, acute kidney injury, endocrine dysfunction and sepsis.

He has published over 350 peer-reviewed research publications,(including 17 papers in the New England Journal of Medicine and 7 in JAMA) and 45 book chapters and monographs. His h-index is 78, calculated from 244 publications yielding over 23700 citations, with a citation trajectory of 900 to 2570 citations per annum from 2010 to the present.

From the Australian National Health and Medical Research Council, he has been awarded 2 Practitioner and 2 Leadership Fellowships; 17 Project Grants and 2 Enabling Grants as Chief Investigator; 6 Project Grants and 1 Centre of Research Excellence grant as Associate Investigator for a total of over A$68M since 1998. In addition to 5 Medical Research Future Fund grants, 15 international, 26 institutional peer-reviewed grants and 5 unrestricted commercial grants, his total cumulative career research funding is over A$125M.

He is a Foundation Member and Past-Chairman of the Australian and New Zealand Intensive Care Society Clinical Trials Group. In 2006, he was instrumental in the establishment of the Australian and New Zealand Intensive Care Research Centre at the Monash University School of Public Health and Preventive Medicine.

In 2006, he established the Division of Critical Care and Trauma at the George Institute for Global Health and has developed programs of research including new opportunities for clinician-researchers for over 20 PhD, post-doctoral and masters’ students and over 50 honorary appointments. He has delivered over 500 presentations at national and international scientific meetings since 1994, including over 50 plenary presentations at major scientific congresses.

He has received five major research awards including the International Sepsis Forum Award in 2007 and two University of New South Wales Research Excellence awards in 2010 and 2013. He was listed on the Australian and New Zealand Intensive Care Society Honour Roll in 2013 and the National Health and Medical Research Council Peer Review Honour Rolls from 2015-2026. He served on the Council of the World Federation of Societies of Intensive and Critical Care Medicine for six years and as Secretary-General from 2017-2019.

He has reviewed manuscripts for over 35 national and international journals and sits on 2 journal editorial boards. He has assessed grants for 12 funding agencies including the National Health and Medical Research Council, the Medical Research Council of the United Kingdom and the Canadian Institute for Health Research.

In addition to his research profile, he has made a substantive contribution to education in Intensive Care Medicine, both at undergraduate and postgraduate levels over the last 30 years. He was instrumental in establishing the College of Intensive Care Medicine, serving as a Fellowship examiner for twelve years, on the Board for ten years and as the first elected President from 2010-2012.

In the 2014 Queen’s Birthday honours, he was made an Officer of the Order of Australia (AO) for distinguished service to medicine as an intensive care medical practitioner, educator and researcher, and as an international innovator in patient management.

In 2015, he was made a Fellow of the Australian Academy of Health and Medical Science.

In 2017, he was awarded the College of Intensive Care Medicine Medal.

In 2019, he was awarded a Doctor of Science from the Faculty of Medicine, University of New South Wales.

Julie Redfern is Deputy Director, Cardiovascular Division at The George Institute for Global Health, an Associate Professor in the Faculty of Medicine at the University of Sydney and a practising Physiotherapist.  

Julie is an advocate for effective secondary prevention of cardiovascular disease and her research interest is focused on improving clinical practice and reduction of risk factors ultimately in people with a range of chronic diseases.  A/Professor Redfern holds a NHMRC Career Development and Heart Foundation Future Leader Fellowship. She was recently selected on the World Heart Federation Emerging Leader Program and concluded a 6 year term on the CSANZ Board and as Chair of the Allied Health Council.

She is currently the Co-Chair of the Clinical and Preventative Cardiology Council of the Cardiac Society of Australia and New Zealand, Co-Chair of the National Secondary Prevention Alliance and part of the team that won the 2016 Australian Google Impact Challenge. Julie’s research aims to improve access to and engagement with secondary prevention strategies with a focus on technology.

Dr Kate Hunter, PhD, MPH is a senior research fellow with Guunu-maana (Heal), Aboriginal and Torres Strait Islander Health program at The George Institute and conjoint senior lecturer at the University of NSW. She is elected chair of Kidsafe NSW (2018-current) and an elected Executive member of the Australasian Injury Prevention Network (2019-current). Working at the knowledge interface – bringing together Indigenous and western knowledges - Dr Hunter’s expertise is in applying an equity lens across the injury prevention spectrum through the conduct and evaluation of complex community and hospital-based programs, ensuring Aboriginal and Torres Strait Islander voices are central to her work.

Dr Hunter prioritises translational research. She has a track record in scale-up of successful programs, with her research being cited in policy and national guidelines. Dr Hunter is committed to supporting the next generation of Aboriginal and/or Torres Strait Islander and non-Aboriginal researchers working in partnership with Aboriginal communities and organisations. She has supervised four Aboriginal and Torres Strait Islander PhD candidates to completion.

Dr Kelly Thompson is a National Health and Medical Research Council of Australia Emerging Leader with The George Institute for Global Health. Concurrently she is Director of Research Operations at Nepean Blue Mountains Local Health District. 

She holds a Doctor of Philosophy and Master of Public Health from the School of Population Health within the Faculty of Medicine at UNSW, Sydney. She is a Registered Nurse, with a Bachelor of Nursing from the University of Newcastle, with clinical experience in intensive care. 

Kelly's primary research interest is in health equity in the clinical area of infection and sepsis. She uses population level data to understand and improve equity in health outcomes for survivors of sepsis and critical illness.  

Laurent is Director of Biostatistics and Data Science at the George Institute for Global Health and Professor at the Faculty of Medicine of the University of New South Wales. He also holds an adjunct professorial appointment at the University of Bordeaux. 

His research focuses on biostatistics and their application to clinical and health services research. He is recognised internationally for his leading role in the design and analysis of large-scale trials in critical care, cardiovascular, neurological and musculoskeletal diseases.

He holds a Master of Science in Statistics and Computer Science and a Master of Research in Public Health (Biostatistics). He is an accredited statistician by the Statistical Society of Australia (AStat).